Emily Weg is the director of genitourinary malignancies at Weill Cornell Medicine / New York Presbyterian. She is proficient in treating patients with IMRT, SBRT, MR-guided adaptive therapy, proton therapy, and brachytherapy and is committed to a multidisciplinary approach to cancer care. Her research interests include prostate cancer genomics, metastasis directed therapy, and radioligand therapy.
Disclosures:
- Employment: none
- Compensation: none
- Ownership: none
- Leadership: none